Table of Contents Author Guidelines Submit a Manuscript
Pulmonary Medicine
Volume 2013 (2013), Article ID 874161, 10 pages
http://dx.doi.org/10.1155/2013/874161
Review Article

Using Cell-Based Strategies to Break the Link between Bronchopulmonary Dysplasia and the Development of Chronic Lung Disease in Later Life

1Department of Pediatrics, Women and Children’s Health Research Institute, Katz Group Centre for Pharmacy and Health Research, University of Alberta, Edmonton, AB, Canada T6G 2E1
2Sprott Centre for Stem Cell Research, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, ON, Canada K1H 8L6
3Division of Neonatology, Department of Pediatrics, Children's Hospital of Eastern Ontario (CHEO) and CHEO Research Institute, 401 Smyth Road, Ottawa, ON, Canada K1H 5B2

Received 7 September 2012; Accepted 16 December 2012

Academic Editor: Leif Bjermer

Copyright © 2013 Megan O'Reilly and Bernard Thébaud. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Harding and G. Maritz, “Maternal and fetal origins of lung disease in adulthood,” Seminars in Fetal & Neonatal Medicine, vol. 17, pp. 67–72, 2012. View at Google Scholar
  2. P. M. Wong, A. N. Lees, J. Louw et al., “Emphysema in young adult survivors of moderate-to-severe bronchopulmonary dysplasia,” European Respiratory Journal, vol. 32, no. 2, pp. 321–328, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. J. R. Bourbon, O. Boucherat, J. Boczkowski, B. Crestani, and C. Delacourt, “Bronchopulmonary dysplasia and emphysema: in search of common therapeutic targets,” Trends in Molecular Medicine, vol. 15, no. 4, pp. 169–179, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Warburton, D. Tefft, A. Mailleux et al., “Do lung remodeling, repair, and regeneration recapitulate respiratory ontogeny?” American Journal of Respiratory and Critical Care Medicine, vol. 164, no. 10, pp. S59–S62, 2001. View at Google Scholar · View at Scopus
  5. L. A. Joss-Moore, K. H. Albertine, and R. H. Lane, “Epigenetics and the developmental origins of lung disease,” Molecular Genetics and Metabolism, vol. 104, pp. 61–66, 2011. View at Google Scholar
  6. J. P. Kinsella, A. Greenough, and S. H. Abman, “Bronchopulmonary dysplasia,” Lancet, vol. 367, no. 9520, pp. 1421–1431, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. S. M. Schulzke and J. J. Pillow, “The management of evolving bronchopulmonary dysplasia,” Paediatric Respiratory Reviews, vol. 11, no. 3, pp. 143–148, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. D. J. Henderson-Smart, J. L. Hutchinson, D. A. Donoghue, N. J. Evans, J. M. Simpson, and I. Wright, “Prenatal predictors of chronic lung disease in very preterm infants,” Archives of Disease in Childhood: Fetal and Neonatal Edition, vol. 91, no. 1, pp. F40–F45, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Ralser, W. Mueller, C. Haberland et al., “Rehospitalization in the first 2 years of life in children born preterm,” Acta Paediatrica, vol. 101, no. 1, pp. e1–e5, 2012. View at Google Scholar
  10. L. Friedrich, P. M. C. Pitrez, R. T. Stein, M. Goldani, R. Tepper, and M. H. Jones, “Growth rate of lung function in healthy preterm infants,” American Journal of Respiratory and Critical Care Medicine, vol. 176, no. 12, pp. 1269–1273, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. O. Hjalmarson and K. Sandberg, “Abnormal lung function in healthy preterm infants,” American Journal of Respiratory and Critical Care Medicine, vol. 165, no. 1, pp. 83–87, 2002. View at Google Scholar · View at Scopus
  12. L. Friedrich, R. T. Stein, P. M. C. Pitrez, A. L. Corso, and M. H. Jones, “Reduced lung function in healthy preterm infants in the first months of life,” American Journal of Respiratory and Critical Care Medicine, vol. 173, no. 4, pp. 442–447, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. S. J. Gross, D. M. Iannuzzi, D. A. Kveselis, and R. D. Anbar, “Effect of preterm birth on pulmonary function at school age: A prospective controlled study,” Journal of Pediatrics, vol. 133, no. 2, pp. 188–192, 1998. View at Google Scholar · View at Scopus
  14. B. Robin, Y. J. Kim, J. Huth et al., “Pulmonary Function in Bronchopulmonary Dysplasia,” Pediatric Pulmonology, vol. 37, no. 3, pp. 236–242, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. R. S. Tepper, W. J. Morgan, K. Cota, and L. M. Taussig, “Expiratory flow limitation in infants with bronchopulmonary dysplasia,” Journal of Pediatrics, vol. 109, no. 6, pp. 1040–1046, 1986. View at Google Scholar · View at Scopus
  16. J. E. Balinotti, V. C. Chakr, C. Tiller et al., “Growth of lung parenchyma in infants and toddlers with chronic lung disease of infancy,” American Journal of Respiratory and Critical Care Medicine, vol. 181, no. 10, pp. 1093–1097, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. I. Narang, “Review series: what goes around, comes around: childhood influences on later lung health? Long-term follow-up of infants with lung disease of prematurity,” Chronic Respiratory Disease, vol. 7, pp. 259–269, 2010. View at Google Scholar
  18. J. Fawke, S. Lum, J. Kirkby et al., “Lung function and respiratory symptoms at 11 years in children born extremely preterm: The EPICure study,” American Journal of Respiratory and Critical Care Medicine, vol. 182, no. 2, pp. 237–245, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. L. W. Doyle, “Respiratory function at age 8-9 years in extremely low birthweight/very preterm children born in Victoria in 1991-1992,” Pediatric Pulmonology, vol. 41, no. 6, pp. 570–576, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. E. B. Broström, P. Thunqvist, G. Adenfelt, E. Borling, and M. Katz-Salamon, “Obstructive lung disease in children with mild to severe BPD,” Respiratory Medicine, vol. 104, no. 3, pp. 362–370, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. L. J. Smith, P. P. Van Asperen, K. O. McKay, H. Selvadurai, and D. A. Fitzgerald, “Reduced exercise capacity in children born very preterm,” Pediatrics, vol. 122, no. 2, pp. e287–e293, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Welsh, J. Kirkby, S. Lum et al., “The EPICure study: maximal exercise and physical activity in school children born extremely preterm,” Thorax, vol. 65, no. 2, pp. 165–171, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Santuz, E. Baraldi, P. Zaramella, M. Filippone, and F. Zacchello, “Factors limiting exercise performance in long-term survivors of bronchopulmonary dysplasia,” American Journal of Respiratory and Critical Care Medicine, vol. 152, no. 4, pp. 1284–1289, 1995. View at Google Scholar · View at Scopus
  24. C. E. Bolton, J. Stocks, E. Hennessy et al., “The EPICure Study: Association between hemodynamics and lung function at 11 years after extremely preterm birth,” Journal of Pediatrics, vol. 161, no. 4, pp. 595–601, 2012. View at Google Scholar
  25. H. Clemm, O. Roksund, E. Thorsen, G. E. Eide, T. Markestad, and T. Halvorsen, “Aerobic capacity and exercise performance in young people born extremely preterm,” Pediatrics, vol. 129, pp. e97–e105, 2012. View at Google Scholar
  26. D. F. Hacking, A. M. Gibson, C. Robertson, and L. W. Doyle, “Respiratory function at age 8-9 after extremely low birthweight or preterm birth in Victoria in 1997,” Pediatric Pulmonology. In press.
  27. E. Kaplan, E. B. Yishay, D. Prais et al., “Encouraging pulmonary outcome for surviving, neurologically intact extremely premature infants in the post surfactant era,” Chest, vol. 142, no. 3, pp. 725–733, 2012. View at Google Scholar
  28. P. Korhonen, J. Laitinen, E. Hyödynmaa, and O. Tammela, “Respiratory outcome in school-aged, very-low-birth-weight children in the surfactant era,” Acta Paediatrica, vol. 93, no. 3, pp. 316–321, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. S. J. Kotecha, W. J. Watkins, S. Paranjothy, F. D. Dunstan, A. J. Henderson, and S. Kotecha, “Effect of late preterm birth on longitudinal lung spirometry in school age children and adolescents,” Thorax, vol. 67, pp. 54–61, 2012. View at Google Scholar
  30. K. Kulasekaran, P. H. Gray, and B. Masters, “Chronic lung disease of prematurity and respiratory outcome at eight years of age,” Journal of Paediatrics and Child Health, vol. 43, no. 1-2, pp. 44–48, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. X. M. Mai, P. O. Gäddlin, L. Nilsson et al., “Asthma, lung function and allergy in 12-year-old children with very low birth weight: a prospective study,” Pediatric Allergy and Immunology, vol. 14, no. 3, pp. 184–192, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Halvorsen, B. T. Skadberg, G. E. Eide, O. D. Røksund, K. H. Carlsen, and P. Bakke, “Pulmonary outcome in adolescents of extreme preterm birth: a regional cohort study,” Acta Paediatrica, International Journal of Paediatrics, vol. 93, no. 10, pp. 1294–1300, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. L. W. Doyle, B. Faber, C. Callanan, N. Freezer, G. W. Ford, and N. M. Davis, “Bronchopulmonary dysplasia in very low birth weight subjects and lung function in late adolescence,” Pediatrics, vol. 118, no. 1, pp. 108–113, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. I. Narang, M. Rosenthal, D. Cremonesini, M. Silverman, and A. Bush, “Longitudinal evaluation of airway function 21 years after preterm birth,” American Journal of Respiratory and Critical Care Medicine, vol. 178, no. 1, pp. 74–80, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. E. J. L. E. Vrijlandt, J. Gerritsen, H. M. Boezen, R. G. Grevink, and E. J. Duiverman, “Lung function and exercise capacity in young adults born prematurely,” American Journal of Respiratory and Critical Care Medicine, vol. 173, no. 8, pp. 890–896, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Filippone, G. Bonetto, M. Corradi, A. C. Frigo, and E. Baraldi, “Evidence of unexpected oxidative stress in airways of adolescents born very preterm,” European Respiratory Journal, vol. 40, no. 5, pp. 1253–1259, 2012. View at Google Scholar
  37. S. M. Aukland, K. Rosendahl, C. M. Owens, K. R. Fosse, G. E. Eide, and Halvorsen, “Neonatal bronchopulmonary dysplasia predicts abnormal pulmonary HRCT scans in long-term survivors of extreme preterm birth,” Thorax, vol. 64, no. 5, pp. 405–410, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. G. Sharma and J. Goodwin, “Effect of aging on respiratory system physiology and immunology.,” Clinical interventions in aging, vol. 1, no. 3, pp. 253–260, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. L. Wang, F. H. Y. Green, S. M. Smiley-Jewell, and K. E. Pinkerton, “Susceptibility of the aging lung to environmental injury,” Seminars in Respiratory and Critical Care Medicine, vol. 31, no. 5, pp. 539–553, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. K. E. Pinkerton and F. H. Y. Green, “Normal Aging of the Lung,” in The Lung: Development, Aging and the Environment, R. Harding, K. E. Pinkerton, and C. G. Plopper, Eds., pp. 213–233, Elsevier, London, UK, 2004. View at Google Scholar
  41. K. C. Meyer, “Aging,” Proceedings of the American Thoracic Society, vol. 2, pp. 433–439, 2005. View at Google Scholar
  42. K. C. Meyer, W. Ershler, N. S. Rosenthal, X. G. Lu, and K. Peterson, “Immune dysregulation in the aging human lung,” American Journal of Respiratory and Critical Care Medicine, vol. 153, no. 3, pp. 1072–1079, 1996. View at Google Scholar · View at Scopus
  43. M. Filippone and E. Baraldi, “On early life risk factors for COPD,” American Journal of Respiratory and Critical Care Medicine, vol. 183, no. 3, pp. 415–416, 2011. View at Google Scholar · View at Scopus
  44. A. H. Jobe, “The new bronchopulmonary dysplasia,” Current Opinion in Pediatrics, vol. 23, no. 2, pp. 167–172, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. C. Agostini, “Stem cell therapy for chronic lung diseases: hope and reality,” Respiratory Medicine, vol. 104, no. 1, pp. S86–S91, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. C. J. Blaisdell, D. B. Gail, and E. G. Nabel, “National heart, lung, and blood institute perspective: lung progenitor and stem cells—gaps in knowledge and future opportunities,” Stem Cells, vol. 27, no. 9, pp. 2263–2270, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. V. Sueblinvong and D. J. Weiss, “Stem cells and cell therapy approaches in lung biology and diseases,” Translational Research, vol. 156, no. 3, pp. 188–205, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. T. Van Haaften, R. Byrne, S. Bonnet et al., “Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats,” American Journal of Respiratory and Critical Care Medicine, vol. 180, no. 11, pp. 1131–1142, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. C. D. Baker, S. L. Ryan, D. A. Ingram, G. J. Seedorf, S. H. Abman, and V. Balasubramaniam, “Endothelial colony-forming cells from preterm infants are increased and more susceptible to hyperoxia,” American Journal of Respiratory and Critical Care Medicine, vol. 180, no. 5, pp. 454–461, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Borghesi, M. Massa, R. Campanelli et al., “Circulating endothelial progenitor cells in preterm infants with bronchopulmonary dysplasia,” American Journal of Respiratory and Critical Care Medicine, vol. 180, no. 6, pp. 540–546, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. X. Liu and C. Xie, “Human endothelial progenitor cells isolated from COPD patients are dysfunctional,” Molecular and Cellular Biochemistry, vol. 363, pp. 53–63, 2012. View at Google Scholar
  52. F. Timmermans, J. Plum, M. C. Yöder, D. A. Ingram, B. Vandekerckhove, and J. Case, “Endothelial progenitor cells: identity defined?” Journal of Cellular and Molecular Medicine, vol. 13, no. 1, pp. 87–102, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. E. K. Kim, J. H. Lee, H. C. Jeong et al., “Impaired colony-forming capacity of circulating endothelial progenitor cells in patients with emphysema,” The Tohoku Journal of Experimental Medicine, vol. 227, pp. 321–331, 2012. View at Google Scholar
  54. M. Aslam, R. Baveja, O. D. Liang et al., “Bone marrow stromal cells attenuate lung injury in a murine model of neonatal chronic lung disease,” American Journal of Respiratory and Critical Care Medicine, vol. 180, no. 11, pp. 1122–1130, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. K. A. Tropea, E. Leder, M. Aslam et al., “Bronchioalveolar stem cells increase after mesenchymal stromal cell treatment in a mouse model of bronchopulmonary dysplasia,” American Journal of Physiology, vol. 302, pp. L829–L837, 2012. View at Google Scholar
  56. X. Zhang, H. Wang, Y. Shi et al., “The role of bone marrow-derived mesenchymal stem cells in the prevention of hyperoxia-induced lung injury in newborn mice,” Cell Biology International, vol. 36, pp. 589–594, 2012. View at Google Scholar
  57. G. Hansmann, A. Fernandez-Gonzalez, M. Aslam et al., “Mesenchymal stem cell-mediated reversal of bronchopulmonary dysplasia and associated pulmonary hypertension,” Pulmonary Circulation, vol. 2, pp. 170–181, 2012. View at Google Scholar
  58. M. Pierro, L. Ionescu, T. Montemurro et al., “Short-term, long-term and paracrine effect of human umbilical cord-derived stem cells in lung injury prevention and repair in experimental bronchopulmonary dysplasia,” Thorax. In press.
  59. Y. S. Chang, S. J. Choi, D. K. Sung et al., “Intratracheal transplantation of human umbilical cord blood derived mesenchymal stem cells dose-dependently attenuates hyperoxia-induced lung injury in neonatal rats,” Cell Transplantation, vol. 20, pp. 1843–1854, 2011. View at Google Scholar
  60. Y. S. Chang, W. Oh, S. J. Choi et al., “Human umbilical cord blood-derived mesenchymal stem cells attenuate hyperoxia-induced lung injury in neonatal rats,” Cell Transplantation, vol. 18, no. 8, pp. 869–886, 2009. View at Publisher · View at Google Scholar · View at Scopus
  61. J. W. Huh, S. Y. Kim, J. H. Lee et al., “Bone marrow cells repair cigarette smoke-induced emphysema in rats,” American Journal of Physiology, vol. 301, pp. L255–L266, 2011. View at Google Scholar
  62. G. Zhen, H. Liu, N. Gu, H. Zhang, Y. Xu, and Z. Zhang, “Mesenchymal stem cells transplantation protects against rat pulmonary emphysema,” Frontiers in Bioscience, vol. 13, no. 9, pp. 3415–3422, 2008. View at Publisher · View at Google Scholar · View at Scopus
  63. N. Shigemura, M. Okumura, S. Mizuno et al., “Lung tissue engineering technique with adipose stromal cells improves surgical outcome for pulmonary emphysema,” American Journal of Respiratory and Critical Care Medicine, vol. 174, no. 11, pp. 1199–1205, 2006. View at Publisher · View at Google Scholar · View at Scopus
  64. N. Shigemura, M. Okumura, S. Mizuno, Y. Imanishi, T. Nakamura, and Y. Sawa, “Autologous transplantation of adipose tissue-derived stromal cells ameliorates pulmonary emphysema,” American Journal of Transplantation, vol. 6, no. 11, pp. 2592–2600, 2006. View at Publisher · View at Google Scholar · View at Scopus
  65. A. M. Katsha, S. Ohkouchi, H. Xin et al., “Paracrine factors of multipotent stromal cells ameliorate lung injury in an elastase-induced emphysema model,” Molecular Therapy, vol. 19, no. 1, pp. 196–203, 2011. View at Publisher · View at Google Scholar · View at Scopus
  66. M. Kumamoto, T. Nishiwaki, N. Matsuo, H. Kimura, and K. Matsushima, “Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury,” European Respiratory Journal, vol. 34, no. 3, pp. 740–748, 2009. View at Publisher · View at Google Scholar · View at Scopus
  67. Y. Moodley, D. Atienza, U. Manuelpillai et al., “Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury,” American Journal of Pathology, vol. 175, no. 1, pp. 303–313, 2009. View at Publisher · View at Google Scholar · View at Scopus
  68. L. A. Ortiz, M. DuTreil, C. Fattman et al., “Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 26, pp. 11002–11007, 2007. View at Publisher · View at Google Scholar · View at Scopus
  69. L. A. Ortiz, F. Gambelli, C. McBride et al., “Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 14, pp. 8407–8411, 2003. View at Publisher · View at Google Scholar · View at Scopus
  70. M. Rojas, J. Xu, C. R. Woods et al., “Bone marrow-derived mesenchymal stem cells in repair of the injured lung,” American Journal of Respiratory Cell and Molecular Biology, vol. 33, no. 2, pp. 145–152, 2005. View at Publisher · View at Google Scholar · View at Scopus
  71. J. W. Lee, X. Fang, A. Krasnodembskaya, J. P. Howard, and M. A. Matthay, “Concise review: mesenchymal stem cells for acute lung injury: role of paracrine soluble factors,” Stem Cells, vol. 29, no. 6, pp. 913–919, 2011. View at Publisher · View at Google Scholar · View at Scopus
  72. V. Balasubramaniam, S. L. Ryan, G. J. Seedorf et al., “Bone marrow-derived angiogenic cells restore lung alveolar and vascular structure after neonatal hyperoxia in infant mice,” American Journal of Physiology, vol. 298, no. 3, pp. L315–L323, 2010. View at Publisher · View at Google Scholar · View at Scopus
  73. P. Vosdoganes, R. J. Hodges, R. Lim et al., “Human amnion epithelial cells as a treatment for inflammation-induced fetal lung injury in sheep,” American Journal of Obstetrics and Gynecology, vol. 205, no. 2, pp. 156.e26–156.e33, 2011. View at Publisher · View at Google Scholar · View at Scopus
  74. Y. Moodley, S. Ilancheran, C. Samuel et al., “Human amnion epithelial cell transplantation abrogates lung fibrosis and augments repair,” American Journal of Respiratory and Critical Care Medicine, vol. 182, no. 5, pp. 643–651, 2010. View at Publisher · View at Google Scholar · View at Scopus
  75. S. Murphy, R. Lim, H. Dickinson et al., “Human amnion epithelial cells prevent bleomycin-induced lung injury and preserve lung function,” Cell Transplantation, vol. 20, pp. 909–923, 2011. View at Google Scholar
  76. A. E. Hegab, H. Kubo, N. Fujino et al., “Isolation and characterization of murine multipotent lung stem cells,” Stem Cells and Development, vol. 19, no. 4, pp. 523–535, 2010. View at Publisher · View at Google Scholar · View at Scopus
  77. D. Wang, J. E. Morales, D. G. Calame, J. L. Alcorn, and R. A. Wetsel, “Transplantation of human embryonic stem cell-derived alveolar epithelial type II cells abrogates acute lung injury in mice,” Molecular Therapy, vol. 18, no. 3, pp. 625–634, 2010. View at Publisher · View at Google Scholar · View at Scopus
  78. S. Aguilar, C. J. Scotton, K. McNulty et al., “Bone marrow stem cells expressing keratinocyte growth factor via an inducible lentivirus protects against bleomycin-induced pulmonary fibrosis,” PLoS ONE, vol. 4, no. 11, article e8013, 2009. View at Publisher · View at Google Scholar · View at Scopus